Literature DB >> 15260821

The serological and genetic basis of the cis-AB blood group in Korea.

D Cho1, S-H Kim, M-J Jeon, K-L Choi, S-J Kee, M-G Shin, J-H Shin, S-P Suh, M H Yazer, D-W Ryang.   

Abstract

BACKGROUND AND OBJECTIVES: The cis-AB blood group is rare, although relatively common amongst Koreans. The serological characteristics and genetic basis of Korean cis-AB blood donors were investigated.
MATERIALS AND METHODS: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), designed to detect the cis-AB01 allele, was performed on 194 AB samples which demonstrated weak or unusual expression of either or both of the A or B antigens. RESULTS AND
CONCLUSIONS: Sixty cis-AB01 donors were identified. cis-AB01/O01 or O02 were the most common genotypes (36/60) detected only in A(2)B(3) donors, and cis-AB01/B101 (nine of 60) was the least common genotype identified only in A(2)B donors. Surprisingly cis-AB01/A102 (15/60) was identified in a variety of phenotypes (A(1)B(3), A(1)B(x) or el, A(int)B(3)).

Mesh:

Substances:

Year:  2004        PMID: 15260821     DOI: 10.1111/j.1423-0410.2004.00528.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  12 in total

1.  A new method for ABO genotyping to avoid discrepancy between genetic and serological determinations.

Authors:  Kaori Shintani-Ishida; Bao-Li Zhu; Hitoshi Maeda; Koichi Uemura; Ken-Ichi Yoshida
Journal:  Int J Legal Med       Date:  2007-01-23       Impact factor: 2.686

2.  Evaluation of kodecytes using function-spacer-lipid constructs as a survey material for external proficiency testing for ABO subgrouping.

Authors:  Young Ae Lim; Seon Joo Kang
Journal:  J Clin Lab Anal       Date:  2017-01-26       Impact factor: 2.352

3.  Molecular genetic analysis of weak ABO subgroups in the Chinese population reveals ten novel ABO subgroup alleles.

Authors:  Haobo Huang; Sha Jin; Xi Liu; Zhongying Wang; Qiong Lu; Liangfeng Fan; Wei Shen; Hang Lei; Chengrui Qian; Xuefeng Wang; Dong Xiang; Xiaohong Cai
Journal:  Blood Transfus       Date:  2018-09-03       Impact factor: 3.443

4.  Application of Blood Group Genotyping by Next-Generation Sequencing in Various Immunohaematology Cases.

Authors:  Tae Yeul Kim; HongBi Yu; Minh-Trang Thi Phan; Ja-Hyun Jang; Duck Cho
Journal:  Transfus Med Hemother       Date:  2021-08-11       Impact factor: 4.040

5.  Allelic Prevalence of ABO Blood Group Genes in Iranian Azari Population.

Authors:  Mohammad Nojavan; Karrim Shamsasenjan; Ali Akbar Movassaghpour; Parvin Akbarzadehlaleh; Seyd Esmail Torabi; Morteza Ghojazadeh
Journal:  Bioimpacts       Date:  2012-06-25

6.  Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population.

Authors:  Hye-Rim Song; Min-Ho Shin; Hee Nam Kim; Jin-Mei Piao; Jin-Su Choi; Jun-Eul Hwang; Young-Kyu Park; Dong-Wook Ryang; Duck Cho; Sun-Seog Kweon
Journal:  Gastric Cancer       Date:  2012-08-03       Impact factor: 7.370

7.  ABO Mistyping of cis-AB Blood Group by the Automated Microplate Technique.

Authors:  Sejong Chun; Mi Ra Ryu; Seung-Yeon Cha; Ji-Young Seo; Duck Cho
Journal:  Transfus Med Hemother       Date:  2018-01-03       Impact factor: 3.747

8.  The cis-AB01 allele originated from the A105 allele, and not from the A102 allele.

Authors:  Sung-Jin Yang; Eun Jeong Won; Duck Cho; Myung-Geun Shin; Dong-Wook Ryang
Journal:  Ann Lab Med       Date:  2015-02-12       Impact factor: 3.464

9.  A dispermic chimera with mixed field blood group B and mosaic 46,XY/47,XYY karyotype.

Authors:  Duck Cho; Sang Ku Lee; Mark Harris Yazer; Myung Geun Shin; Jong Hee Shin; Soon Pal Suh; Jeong Won Song; Mee Jeong Jeon; Ji Young Kim; Jong Tae Park; Dong Wook Ryang
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

10.  Identification of the ABO*cis-AB04 Allele With a Unique Substitution C796A: The First Case in Korea.

Authors:  Jung Yoon; Hee Jeong Youk; Jung Hee Chang; Mi Ae Jang; Ji Ho Choi; Myung Hyun Nam; Ji Seon Choi; Chae Seung Lim
Journal:  Ann Lab Med       Date:  2016-11       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.